Beam Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	294.94	281.97	435.9	232.77	559.99
Short-Term Investments	950.27	568.77	753.98	845.37	405.65
Cash & Short-Term Investments	1,245	850.74	1,190	1,078	965.65
Cash Growth	46.37%	-28.50%	10.36%	11.65%	222.24%
Receivables	-	-	-	-	300
Prepaid Expenses	23.48	27.41	21.17	14.76	7.36
Total Current Assets	1,269	878.15	1,211	1,093	1,273
Property, Plant & Equipment	205.18	216.28	237.81	234.13	186.98
Other Long-Term Assets	7.31	9.4	10.87	14.69	14.47
Total Assets	1,481	1,104	1,460	1,342	1,474
Accounts Payable	10.23	3.87	1.62	9.03	7.47
Accrued Expenses	49.64	36.13	35.05	30.72	56.87
Current Portion of Leases	14.36	13.47	12.78	12.23	9.83
Current Unearned Revenue	6.66	108.86	68.71	135.97	86.27
Other Current Liabilities	16.05	19.74	87.42	35.64	53
Total Current Liabilities	96.94	182.07	205.57	223.6	213.44
Long-Term Leases	139.76	147.96	159.91	168.63	137.82
Long-Term Unearned Revenue	-	33.22	109.89	202.18	262.3
Other Long-Term Liabilities	6.13	7.04	3.02	13.84	34.16
Total Liabilities	242.82	370.28	478.39	608.24	647.72
Common Stock	1.02	0.84	0.82	0.71	0.68
Additional Paid-In Capital	2,877	2,299	2,170	1,793	1,594
Retained Earnings	-1,641	-1,567	-1,190	-1,057	-768.27
Comprehensive Income & Other	1.11	0.68	0.6	-2.43	-0.05
Total Common Equity	1,238	733.55	981.33	733.47	826.74
Shareholders' Equity	1,238	733.55	981.33	733.47	826.74
Total Liabilities & Equity	1,481	1,104	1,460	1,342	1,474
Total Debt	154.12	161.43	172.69	180.86	147.64
Net Cash (Debt)	1,091	689.32	1,017	897.28	818
Net Cash Growth	58.29%	-32.23%	13.36%	9.69%	325.98%
Net Cash Per Share	11.03	8.37	13.18	12.82	12.74
Filing Date Shares Outstanding	99.31	81.11	78.73	70.7	67.6
Total Common Shares Outstanding	99.21	81.06	78.71	69.58	67.26
Working Capital	1,172	696.08	1,005	869.3	1,060
Book Value Per Share	12.48	9.05	12.47	10.54	12.29
Tangible Book Value	1,238	733.55	981.33	733.47	826.74
Tangible Book Value Per Share	12.48	9.05	12.47	10.54	12.29
Machinery	85.04	79.79	69.67	54.79	35.23
Construction In Progress	2.82	2.53	5.28	5.2	7.35
Leasehold Improvements	110.76	101.2	100.19	85.8	57.76

Source: S&P Global Market Intelligence. Standard template. Financial Sources.